FDA warns of foot, leg amputations with J&J diabetes drug

(Reuters) - Johnson & Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration said on Tuesday.